RxDoctor Payments Data

David Kim, MD

Plastic and Reconstructive Surgery · Philadelphia, PANPI 1235517996

Payments from drug & device makers

What this record shows

13 manufacturers reported payments, led by Integra Lifesciences Corporation at 59.5% of the total. 2025 is the largest year on record at $1,601, 6.7 times the $239 reported in 2022.

$1,975in general payments, 2019–2025

Across 23 payments — averaging $85.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • AbbVie$176
  • Musculoskeletal Transplant Foundation Inc.$164
  • Medline Industries LP$144
  • Axogen$95
  • Smith+Nephew$45
  • plus $175 from 7 others

What the payments were for

  • Travel & lodging$92547%
  • Food & beverage$1,05053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,975 in reported general payments places this provider in the 55th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$18,061
Medicare patients
19
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →